|
| Non-Hormone Treatments Can Relieve Hot Flashes In Women With Breast Cancer | Wed, 08 Sep 2010 |
| Many women enduring hot flashes experience the heat, sweat and reddened upper body as an uncomfortable inconvenience. However, hot flashes can greatly diminish a woman's quality of life, disrupting sleep at night or causing embarrassment as she goes about her daily business. Hot flashes, called flushes in medical circles, occur commonly in women with a history of breast cancer... | |
|
|
|
| PIP (Poly Implant Prosthese) Breast Implants - UK Test Results | Mon, 06 Sep 2010 |
| The Medicines and Healthcare products Regulatory Agency (MHRA) has received encouraging results of UK testing on the silicone gel breast implants manufactured by the French company Poly Implant Prosthese (PIP). The tests found no evidence of genotoxicity (potential for cancer) or chemical toxicity of the filler material in the implants... | |
|
|
| Using PET/CT In The Detection Of Breast Cancer Metastases | Sun, 05 Sep 2010 |
| About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread... | |
| 'Basal-Like' Breast Cancer Does Not Originate From Basal Stem Cells | Sat, 04 Sep 2010 |
| New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies. The study, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, suggests that despite their "stem cell-like" characteristics, most aggressive breast tumors are not derived from normal mammary gland stem cells... | |
| Important Breakthrough In Origins Of Aggressive Breast Cancer | Fri, 03 Sep 2010 |
| Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell... | |
| Study: Preemptive Surgery May Help Prevent Cancer For Some Women | Thu, 02 Sep 2010 |
| A study published in the Journal of the American Medical Association suggests that women with a gene mutation linked to breast and ovarian cancer face lower risks of developing such cancer after receiving mastectomies or having their ovaries removed, The Wall Street Journal reports... | |
| Breast Cancer Prognosis Prediction Tool: Microsoft Excel-Based Algorithm | Thu, 02 Sep 2010 |
| Using readily available computer programs, researchers have developed a system to identify genes that will be useful in the classification of breast cancer. The algorithm, described in BioMed Central's open access Journal of Experimental & Clinical Cancer Research will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training... | |
|
| Roche Provides Update On FDA Application For T-DM1 | Thu, 02 Sep 2010 |
| Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study... | |
| Surgeons Impact Whether A Woman Gets Breast Reconstruction | Thu, 02 Sep 2010 |
| When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center. Where a woman goes for breast cancer treatment can vary widely - ranging from small private practices to large hospital settings... | |
|
|
| Link Between High-Fat Diet During Puberty And Breast Cancer Risk Later In Life | Wed, 01 Sep 2010 |
| Girls eating a high-fat diet during puberty, even those who do not become overweight or obese, may be at a greater risk of developing breast cancer later in life, according to Michigan State University researchers. The implications - that a high-fat diet may have detrimental effects independent of its effect to cause obesity - could drive new cancer prevention efforts... | |
|
| Preventive Surgeries Linked To Lower Risk Of Breast And Ovarian Cancer | Wed, 01 Sep 2010 |
| Women with the inherited mutations of the BRCA1 or BRCA2 genes who had preventive (prophylactic) breast removal (mastectomy) or the removal of the fallopian tubes and ovaries (salpingo-oophorectomy) were found to have a significantly lower risk of developing ovarian and breast cancers, says a study published in JAMA (Journal of the American Medical Association), September 1st issue... | |
| Genentech Receives Refuse To File Letter From FDA For T-DM1 | Tue, 31 Aug 2010 |
| ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops antibody-based targeted anticancer products, announced that Genentech, a member of the Roche Group, announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010... | |
|
| Roughly One In Six Cancer Survivors Forgo Some Medical Care Due To Cost, Study Finds | Mon, 30 Aug 2010 |
| AARP Bulletin: "Two years after undergoing a double mastectomy and chemotherapy so severe she was hospitalized in intensive care for several weeks, breast cancer survivor Denise Hicks should be following what her doctors call 'the plan,'" which includes additional medications and treatments. But she can't. "Hicks has health insurance but already reached her coverage limits... | |
| Genentech Provides Update On FDA Application For T-DM1 | Sun, 29 Aug 2010 |
| Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned, Genentech will continue with its ongoing Phase III registrational T-DM1 trial, EMILIA... | |
| 24-hour Test Predicts Breast Cancer's Likely Response To Chemotherapy | Sat, 28 Aug 2010 |
| A new test has been developed which can predict whether a breast cancer patient will respond to chemotherapy within 24-hours of starting treatment, thus sparing her unnecessary treatment and side effects, according to a study published in the medical journal Clinical Cancer Research... | |
